East China’s Jiangsu province has sped up the COVID-19 inoculation campaign by taking multi-pronged measures with a view to ensuring the smooth progress of the prevention and control of the epidemic.
People older than 18 and those above 60 in good health are included in the vaccination on an appointment basis, experts say.
The inactivated vaccine involves two shots, administered 14 days and 28 days apart respectively.
Experts said that multiple vaccinations are usually required for inactivated vaccines to achieve a better immune effect, and the length of the interval between doses is determined based on the results of clinical trials.
The interval ranges from 3 weeks to 8 weeks between two shots, experts say.
In order to better identify and monitor adverse reactions, experts suggest an interval of at least two weeks is needed between the shot of COVID-19 vaccine and other vaccines.
People unfit for the vaccination include those who are allergic to vaccines or vaccine components, those who suffer from acute diseases, those who are in the acute stage of chronic diseases, those who are feverish, and expecting women, according to experts.
The recombinant subunit vaccine will also be put into use in Jiangsu. This vaccine requires three doses with an interval range between 4 and 8 weeks after the first shot and another 4 weeks after the second shot.
The best method to prevent coronavirus infections is to get vaccinated. Through vaccination, individuals can protect themselves and a wider population can also mount protection against the virus, experts say.
People should wear masks and bring their personal ID card. They are advised to stay for half an hour for clinical observation.
The free vaccination will be carried out based on the risks of infection of different groups, and participation will be voluntary.
Officials noted that the country’s annual production can fully meet the inoculation needs of the entire country.
Chinese authorities have reportedly laid out plans to ramp up efforts to vaccinate 560 million people, or 40 percent of China's population, by the end of June, and another 330 million people by the end of the year, covering 64 percent of the total population.
